Technical Analysis for BNTC - Benitec Biopharma Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
5.0616 | -4.14% | -0.22 |
BNTC closed up 8.87 percent on Wednesday, February 19, 2020, on 1.31 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Historical BNTC trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | -4.14% | |
| Crossed Above 50 DMA | Bullish | -4.14% | |
| Stochastic Buy Signal | Bullish | -4.14% | |
| Wide Bands | Range Expansion | -4.14% | |
| Oversold Stochastic | Weakness | -4.14% | |
| 50 DMA Resistance | Bearish | 4.36% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 4.36% | |
| Calm After Storm | Range Contraction | 4.36% | |
| Outside Day | Range Expansion | 4.36% | |
| Wide Bands | Range Expansion | 4.36% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2019
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Benitec Biopharma Limited, a biotechnology company, develops novel treatments for chronic and life-threatening conditions based on its gene silencing technology, DNA-directed RNA interference (ddRNAi). The company's ddRNAi technology provides novel therapeutics to treat a range of human medical diseases and conditions, such as hepatitis C, hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug resistant lung cancer, and oculopharyngeal muscular dystrophy (OPMD). Its pipeline of in-house and partnered therapeutic programs include TT-034 for hepatitis C; Tribetarna for the treatment of chemotherapy resistant non-small cell lung cancer; Hepbarna for Hepatitis B; and Pabparna for the treatment of OPMD. The company also licenses its ddRNAi technology to biopharmaceutical companies for the clinical applications comprising HIV/AIDS, retinitis pigmentosa, and Huntington's disease. Benitec Biopharma Limited was founded in 1997 and is based in Sydney, Australia.
Biotechnology Biopharmaceutical Biology Pain Chemotherapy Genetics Gene Expression Genetic Engineering Hepatitis B HIV/Aids Wet Age Related Macular Degeneration Huntington's Disease RNA Retinitis Pigmentosa Hepatitis C Clinical Applications Oculopharyngeal Muscular Dystrophy Chronic And Life Threatening Conditions
Biotechnology Biopharmaceutical Biology Pain Chemotherapy Genetics Gene Expression Genetic Engineering Hepatitis B HIV/Aids Wet Age Related Macular Degeneration Huntington's Disease RNA Retinitis Pigmentosa Hepatitis C Clinical Applications Oculopharyngeal Muscular Dystrophy Chronic And Life Threatening Conditions
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.0 |
| 52 Week Low | 4.13 |
| Average Volume | 93,047 |
| 200-Day Moving Average | 8.06 |
| 50-Day Moving Average | 4.92 |
| 20-Day Moving Average | 5.04 |
| 10-Day Moving Average | 5.35 |
| Average True Range | 0.83 |
| ADX | 43.8 |
| +DI | 45.04 |
| -DI | 8.42 |
| Chandelier Exit (Long, 3 ATRs ) | 9.13 |
| Chandelier Exit (Short, 3 ATRs ) | 6.89 |
| Upper Bollinger Band | 6.26 |
| Lower Bollinger Band | 3.83 |
| Percent B (%b) | 0.6 |
| BandWidth | 48.32 |
| MACD Line | 0.04 |
| MACD Signal Line | 0.06 |
| MACD Histogram | -0.0208 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.38 | ||||
| Resistance 3 (R3) | 6.31 | 5.88 | 6.19 | ||
| Resistance 2 (R2) | 5.88 | 5.60 | 5.91 | 6.13 | |
| Resistance 1 (R1) | 5.58 | 5.43 | 5.73 | 5.65 | 6.07 |
| Pivot Point | 5.15 | 5.15 | 5.23 | 5.18 | 5.15 |
| Support 1 (S1) | 4.85 | 4.87 | 5.00 | 4.92 | 4.49 |
| Support 2 (S2) | 4.42 | 4.70 | 4.45 | 4.43 | |
| Support 3 (S3) | 4.12 | 4.42 | 4.37 | ||
| Support 4 (S4) | 4.19 |
